Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01856218
Brief Title: An Open-Label Phase 1/2 Study to Assess the Safety, Efficacy and Dose of Study Drug UX003 Recombinant Human Beta-glucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis Type 7 (MPS 7)

First Submitted : May 8, 2013
First Submitted that Met QC Criteria : May 14, 2013
First Posted : May 17, 2013 (Estimate)

Results First Submitted : November 29, 2017
Results First Submitted that Met QC Criteria : December 5, 2017
Results First Posted : January 5, 2018

Certification/Extension First Submitted : May 8, 2017
Certification/Extension First Submitted that Met QC Criteria : May 8, 2017
Certification/Extension First Posted : May 10, 2017

Last Update Submitted that Met QC Criteria : December 12, 2018
Last Update Posted : January 4, 2019